Efficacy, safety and tolerability of simvastatin in children with familial hypercholesterolaemia: Rationale, design and baseline characteristics

Clinical Drug Investigation

Volumn 22, Issue 8, 2002, Pages 533-540

  De Jongh, Saskia ^a   Stalenhoef, Anton F H ^b   Tuohy, Mary B ^d   Kastelein, John J P ^a   Bakker, Henk D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MERCK RESEARCH LABORATORIES   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADOLESCENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIBLING; TREATMENT OUTCOME;

EID: 0036051345     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200222080-00005     Document Type: Article

References (47)

1. Familial hypercholesterolemia
2. Familial hypercholesterolemia: Identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity associated with overproduction of cholesterol
3. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia
4. Higher prevalence of familiar hypercholesterolemia than expected in adult patients of four family practices in Netherlands
5. The molecular basis of familial hypercholesterolemia in The Netherlands
6. Coronary artery disease in 116 kindred with familial type 1I hyperlipoproteinemia
7. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states
8. Familial hypercholesterolemia in Dutch children: Past, present, and future
9. Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the pathobiological determinants of atherosclerosis in youth study
10. Determinants of atherosclerosis in the young: Pathobiological determinants of atherosclerosis in youth (PDAY) research group
11. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study
12. Association of coronary heart disease risk factors with microscopic qualities of coronary atherosclerosis in youth
13. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects
14. Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain
15. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
16. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
17. Pediatric implications of heterozygous familial hypercholesterolemia: Screening and dietary treatment
18. Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: Seven-year results of the dietary intervention study in children (DISC)
19. National cholesterol education program: Report of the expert panel on blood cholesterol levels in children and adolescents
20. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
21. Long-term follow-up of children with familial hypercholesterolaemia treated with cholestyramine
22. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia
23. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
24. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
25. Simvastatin use in children
26. Treatment of hypercholesterolaemia in children
27. Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin
28. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia
29. Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood
30. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: A randomized controlled trial
31. Variations in pattern of pubertal changes in girls
32. Variations in the pattern of pubertal changes in boys
33. The centers for disease control-national heart, lung and blood institute lipid standardization program: An approach to accurate and precise lipid measurements
34. Standardization of micromethods for plasma cholesterol, triglycerides and HDL-cholesterol with the lipid clincs' methodology
35. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol
36. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
37. A model for validation of radioimmunoassay kit reagents: Measurement of follitropin and lutropin in blood and urine
38. Validation of radioimmunoassay for estradiol-17 beta by isotope dilution-mass spectrometry and by a test of radiochemical purity
39. Radioimmunoassay of peptides lacking tyrosine
40. Treatment of familial hypercholesterolemia with drugs in children
41. Use of the body mass index (BMI) as a measure of overweight in children and adolescents
42. Diabetes, impaired fasting glucose, and elevated HbAlc in US adolescents: The Third National Health and Nutrition Examination Survey
43. Biochemical, clinical, epidemiologic, genetic, and pathologic data in the pediatric age group relevant to the cholesterol hypothesis
44. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects